Analysts are forecasting a comeback of the stocks from the pharmaceutical sector. Sun Pharmaceutical is back on the radar and so is Ajanta Pharma. For the purpose of this report, we have selected stocks wherein the count of analysts is at least 5 and the average stock report plus score is a minimum of 7. The reason for having a minimum count of analysts for a particular sector is because higher coverage by analysts indicates higher institutional interest in individual stocks. The list is based on upside potential estimated by the analysts and the stock with the highest potential would be coming on the top of the list.
